Acute myeloid leukemia in the older adults
- PMID: 27408788
- PMCID: PMC4927655
- DOI: 10.1016/j.lrr.2016.06.001
Acute myeloid leukemia in the older adults
Abstract
AML is an aggressive hematological malignancy with highest incidence in the older adults. The adverse features of AML in the elderly, and the frailties and comorbidities frequently present in them, make their management a particularly difficult therapeutic challenge. In this context, it is important to assess carefully patient- as well as disease-associated prognostic features with validated tools. The fittest patients should be considered for curative therapy, such as bone marrow transplantation, whereas low intensity options may be more appropriate for frail patients. Here we review how to assess patients with elderly AML and the treatments options available for them.
Keywords: Acute myeloid leukemia; Elderly; Geriatric assessment; Prognosis; Therapy.
Figures
References
-
- Cancer Statistics Review 1975–2003: I Table–11median age of cancer patients at diagnosis, 2000–2003 by primary cancersite, race and sex. [database on the Internet]. National Cancer Institute. (cited 01.02.16), 2003.
-
- Alibhai S.M., Leach M., Minden M.D., Brandwein J. Outcomes and quality of care in acute myeloid leukemia over 40 years. Cancer. 2009;115(13):2903–2911. - PubMed
-
- Menzin J., Lang K., Earle C.C., Kerney D., Mallick R. The outcomes and costs of acute myeloid leukemia among the elderly. Arch. Intern Med. 2002;162(14):1597–1603. - PubMed
-
- Global Health Observatory Data (database on the Internet). WHO. (cited 01.02.16), 2016. Available from: 〈http://www.who.int/gho/mortality_burden_disease/life_tables/life_tables....
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources